ALTEOGEN
Blood & Organ Banks · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
62 Yuseong-daero 1628beon-Gil Yuseong-gu...Phone Number
+82 423848780Website
www.alteogen.comRevenue
$5.7 MillionStock Symbol
196170Industry
About ALTEOGEN
ALTEOGEN Org Chart
Is ALTEOGEN your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ALTEOGEN recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if ALTEOGEN had a recent Job posting/layoffs
Check if ALTEOGEN has recently received funding, and reach out quickly before it becomes old news!
ALTEOGEN, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ALTEOGEN is spiking on competitors!
Funding: Get notified immidiatlly once ALTEOGEN has new funding data
Product Launch: Get notified when ALTEOGEN launches new products
Congratulate Masked Content for being promoted to Masked Content at ALTEOGEN
Recommended Actions
Find VP level buyers at ALTEOGEN
Find 2 more new buyers
Company Profile Activity
Activity Insights
ALTEOGEN is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
ALTEOGEN is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about ALTEOGEN.
ALTEOGEN Tech Stack
A closer look at the technologies used by ALTEOGEN
Most Recent Scoops
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ALTEOGEN
Alteogen lnc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-Drug Conjugates (ADCs), biobetters and biosimilars. Alteogen's portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexP-fusion and Ne... Read More